Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOXOPROFEN vs LUMASIRAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LOXOPROFEN vs LUMASIRAN: Safety Overview

Metric LOXOPROFEN LUMASIRAN
Total FAERS Reports 1,359 279
Deaths Reported 184 15
Death Rate 13.5% 5.4%
Hospitalizations 819 99
Average Patient Age 60.7 yrs 43.3 yrs
% Female Patients 49.7% 72.7%
FDA Approval Date N/A Nov 23, 2020
Manufacturer N/A Alnylam Pharmaceuticals, Inc.
Route N/A SUBCUTANEOUS
Marketing Status N/A Prescription